The FDA has approved Harvest Technologies’ (HT) sponsored 210 patient IDE clinical trial to be conducted at 25 sites Read more…
Developing a method for converting dermal fibroblasts into regenerative, functional human cell types for applications in autologous cell therapy Read more…
Founder and Director of Research, Henry McCusker enters his tenth (10) year at Scimitar Equity with past experience in sell-side analysis, buy-side management, corporate management and due diligence.
I started this blog to add commentary, update news flow and insightful opinions that are intelligent, fit to print and SEC compliant.